THE US Food and Drug
Administration has approved a
new allergy medicine, Allegra, for
Manufactured by Sanofi-Aventis,
Allegra has been approved for the
treatment of persons aged over
two years, and will be available in
its prescription strength without a
prescription in US pharmacies
from March this year.
MEANWHILE the FDA has also
announced a possible association
between saline and silicone gelfilled
breast implants and
anaplastic large cell lymphoma.
The warning comes on the heels
of data collected by the FDA which
suggests that patients with breast
implants “may have a very small
but significant risk of ALCL in the
scar capsule adjacent to the implant.”The above article was sent to subscribers in Pharmacy Daily's issue from 27 Jan 11 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 27 Jan 11
from the fields Pharmaceutical (FTFP) is unveiling an information drive targeting community pharmacy, ahead of the 01 Mar commencement of new retail regulations for the sale and distribution of medically prescribed vaping products in pharmacies.